Novel implant for macular telangiectasia gains fast-track designation
- Posted on: Feb 15 2019
- Leave a response
The FDA has fast-tracked Neurotech’s implant for stalling central vision loss in people with type 2 macular telangiectasia.
Source: AAO
Posted in: Uncategorized